v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells - PubMed (original) (raw)
. 1996 Nov 1;10(21):2720-31.
doi: 10.1101/gad.10.21.2720.
Affiliations
- PMID: 8946913
- DOI: 10.1101/gad.10.21.2720
Free article
v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells
J Frampton et al. Genes Dev. 1996.
Free article
Abstract
Many oncogenes have been shown to be deregulated transcription factors, yet direct target genes mediating cell transformation remain elusive. Here we describe such a target for v-Myb by exploiting a temperature-sensitive mutant of the E26 avian leukemia virus encoding Myb-Ets. Myeloblasts transformed by the mutant differentiate into macrophages or die by apoptosis when shifted to the nonpermissive temperature as a result of inactivation of v-Myb. During this process mRNA of the antiapoptotic oncoprotein Bcl-2 is down-regulated with kinetics similar to those of Mim-1, a differentiation-related protein whose expression is directly regulated by Myb. Forced expression of bcl-2 rescues the cells from apoptosis, without preventing either their withdrawal from the cell cycle or their differentiation. v-Myb appears to act directly on the bcl-2 gene, because a bcl-2 promoter-driven reporter is activated by Myb-Ets and v-Myb-VP16 and requires intact Myb binding sites within the promoter. Surprisingly, inactivation of v-Myb in multipotent progenitors transformed by E26 virus does not induce apoptosis, indicating that bcl-2 regulation by the oncoprotein is required for the transformation of some cell types but not others.
Similar articles
- v-Myb DNA binding is required to block thrombocytic differentiation of Myb-Ets-transformed multipotent haematopoietic progenitors.
Frampton J, McNagny K, Sieweke M, Philip A, Smith G, Graf T. Frampton J, et al. EMBO J. 1995 Jun 15;14(12):2866-75. doi: 10.1002/j.1460-2075.1995.tb07286.x. EMBO J. 1995. PMID: 7540977 Free PMC article. - The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages.
Domenget C, Leprince D, Pain B, Peyrol S, Li RP, Stehelin D, Samarut J, Jurdic P. Domenget C, et al. Oncogene. 1992 Nov;7(11):2231-41. Oncogene. 1992. PMID: 1331935 - Excision of Ets by an inducible site-specific recombinase causes differentiation of Myb-Ets-transformed hematopoietic progenitors.
Rossi F, McNagny KM, Logie C, Stewart AF, Graf T. Rossi F, et al. Curr Biol. 1996 Jul 1;6(7):866-72. doi: 10.1016/s0960-9822(02)00610-3. Curr Biol. 1996. PMID: 8805301 - Molecular analysis of the ets genes and their products.
Watson DK, Ascione R, Papas TS. Watson DK, et al. Crit Rev Oncog. 1990;1(4):409-36. Crit Rev Oncog. 1990. PMID: 1964597 Review. - Transformation by v-Myb.
Lipsick JS, Wang DM. Lipsick JS, et al. Oncogene. 1999 May 13;18(19):3047-55. doi: 10.1038/sj.onc.1202745. Oncogene. 1999. PMID: 10378700 Review.
Cited by
- MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.
Cicirò Y, Sala A. Cicirò Y, et al. Oncogenesis. 2021 Feb 26;10(2):19. doi: 10.1038/s41389-021-00309-y. Oncogenesis. 2021. PMID: 33637673 Free PMC article. Review. - Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2.
Wilkins HR, Doucet K, Duke V, Morra A, Johnson N. Wilkins HR, et al. Tumour Biol. 2010 Jan;31(1):16-22. doi: 10.1007/s13277-009-0003-2. Epub 2009 Dec 18. Tumour Biol. 2010. PMID: 20237898 - B-Myb as a critical regulator of Bcl-2 in human B cells.
Meyer KB. Meyer KB. Immunology. 2005 Jan;114(1):23-4. doi: 10.1111/j.1365-2567.2004.02093.x. Immunology. 2005. PMID: 15606791 Free PMC article. No abstract available. - Distinct C/EBP functions are required for eosinophil lineage commitment and maturation.
Nerlov C, McNagny KM, Döderlein G, Kowenz-Leutz E, Graf T. Nerlov C, et al. Genes Dev. 1998 Aug 1;12(15):2413-23. doi: 10.1101/gad.12.15.2413. Genes Dev. 1998. PMID: 9694805 Free PMC article. - Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response.
Girirajan S, Hauck PM, Williams S, Vlangos CN, Szomju BB, Solaymani-Kohal S, Mosier PD, White KL Jr, McCoy K, Elsea SH. Girirajan S, et al. Mamm Genome. 2008 Apr;19(4):246-62. doi: 10.1007/s00335-008-9100-6. Epub 2008 Mar 15. Mamm Genome. 2008. PMID: 18343975
MeSH terms
Substances
LinkOut - more resources
Full Text Sources